Results 41 to 50 of about 1,937,228 (299)

COST OF ILLNESS OF INPATIENT PEDIATRIC MENINGITIS PATIENTS HOSPITALIZED IN YOGYAKARTA

Jurnal Farmasi Sains dan Praktis, 2020
This research to determine the average cost of illness of inpatient pediatric meningitis patients hospitalized in the hospitals in Yogyakarta. It was a pharmacoeconomic study using the cost of illness method.
Ingenida Hadning, Dwi Endarti, Tri Murti Andayani, Rina Triasih   +3 more
doaj   +1 more source

The Cost of Von Willebrand Disease in Europe: The CVESS Study

Clinical and Applied Thrombosis/Hemostasis, 2022
Background Von Willebrand disease (VWD) is one of the most common inherited bleeding disorders, imposing a substantial health impact and financial burden.
George Morgan MSc, Sarah Brighton BSc, Mike Laffan BA, BMBCh, DM, FRCP, FRCPath, Jenny Goudemand MD, Bethany Franks MSc, Alan Finnegan PhD, RN, FRCN, FRSA, CF, FAAN   +5 more
doaj   +1 more source

DRGs in Transfusion Medicine and Hemotherapy in Germany [PDF]

, 2012
Patients requiring transfusion medicine and hemotherapy in an inpatient setting are incorporated into the German Diagnosis Related Groups (G-DRG) system in multiple ways.
Bauer, Matthäus, Ostermann, Helmut
core   +2 more sources

Patient-Level Estimates of Diabetic Complications on Direct Medical Cost [PDF]

Value in Health, 2014
link_to_OA_fulltext
Fung, CSC, Jiao, FF, Lam, CLK, Wong, CKH, McGhee, S   +4 more
openaire   +3 more sources

The economic burden of overseas medical treatment: a cross sectional study of Maldivian medical travelers. [PDF]

, 2015
BACKGROUND: Access to tertiary care is a problem common to many small states, especially island ones. Although medical treatment overseas (MTO) may result in cost savings to high income countries, it can be a relatively high cost for low and middle ...
Chongsuvivatwong, Virasakdi, Mills, Anne, Suzana, Mariyam, Tangcharoensathien, Viroj   +3 more
core   +1 more source

A Prevalence-Based Study to Estimate Cost of Illness of Rheumatoid Arthritis in a Tertiary Care Hospital in India

Medical Journal of Dr. D.Y. Patil Vidyapeeth
Background: Rheumatoid arthritis (RA) is a chronic progressive inflammatory condition with high cost of management and significant impact on the patient and healthcare system.
Satish Kumar, Ankit Kumar, A. S. Menon, Seema Patrikar, Someshwar Gaikwad, S. K. Singh   +5 more
doaj   +1 more source

EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control [PDF]

, 2014
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative ...
Andrews, F, Coyle, D, Coyle, K, Crossfield, A, Evers, S, Huic, M, Jones, T, Kalo, Z, Leidl, R, Lester-George, A, Owen, L, Pokhrel, S, Radu-Loghin, C, Rutter, A, Trapero-Bertran, M, Vogl, M, Voko, Z, Vries, HD, West, R   +18 more
core   +5 more sources

Economic burden of osteoporotic fractures in Austria [PDF]

, 2012
Objective: Osteoporotic fractures impose a huge economic burden on society. Though several cost of illness studies from other countries exist, no equivalent study has been conducted in Austria.
Borgström, Fredrik, Dimai, Hans Peter, Mahlich, Jörg, Peretz, Monika, Redlich, Kurt, Siebert, Uwe   +5 more
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective

Health Economics Review, 2021
Background This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice.
Irfan Cicin, Ergun Oksuz, Nuri Karadurmus, Simten Malhan, Mahmut Gumus, Ulku Yilmaz, Levent Cansever, Halit Cinarka, Erdogan Cetinkaya, Murat Kiyik, Ahmet Ozet, Lung Cancer Report Study Group Turkey, on behalf of the Turkish Society of Lung Cancer, Lung Health and Intensive Care Association, University of Health Sciences, Turkish Society of Medical Oncology, National Cancer Institute, Turkish Respiratory Society   +17 more
doaj   +1 more source